XOVOLTIB 30MG (AFATINIB DIMALEATE)
$930.00 – $2,330.00
| Active Ingredient | Afatinib Dimaleate |
|---|---|
| Indication | Non-small cell lung cancer |
| Manufacturer | Boehringer Ingelheim India Pvt.Ltd |
| Packaging | 7 Tablets in 1 strip |
| Strength | 30mg |
| Delivery Time | 6 To 15 days |
- 15% Off Coupan Code GOOD15
- Data Privacy and Security
- Free Shipping on Orders Over $199
| Variation | Price | Quantity | Add To Cart |
|---|---|---|---|
| 28 Tablet/s | $930.00 |
|
Add to cart |
| 56 Tablet/s | $1,730.00 |
|
Add to cart |
| 84 Tablet/s | $2,330.00 |
|
Add to cart |
XOVOLTIB is taken orally, usually once a day, and has been shown to improve outcomes for people with metastatic squamous non-small cell lung cancer. In clinical trials, XOVOLTIB effectively prolongs survival for those with this type of cancer. In addition, those who took it found the drug to be well tolerated, with few side effects reported.
Reviews
There are no reviews yet.